Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wood/Dynamic Covalent Polymer Network Composites.

Polymers·2026
Same author

Preparation of chitosan based fluorescent probe for selective recognition of formaldehyde and acetaldehyde.

International journal of biological macromolecules·2026
Same author

Breathable, biocompatible, long-term stability Ti<sub>3</sub>C<sub>2</sub>T<sub><i>x</i></sub> bioelectrodes for real-time monitoring of electrophysiological signals.

Nanoscale horizons·2026
Same author

Optimizing Strategies of in Situ Loading Photocatalysts in Aramid Nanofiber Aerogels: Harnessing Internal/External Synergistic Photocatalysis for Improving Degradation Efficiency of Pollutants.

ACS applied materials & interfaces·2026
Same author

Synthesis of naphthylimide-quinoline fluorescent probe for the detection of Fe<sup>3+</sup> and its application to Hela cells imaging.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Low-temperature curing, flame-retardant and water-resistant modified cellulose-chitosan adhesive based on organic-inorganic hybridization.

International journal of biological macromolecules·2025

Related Experiment Video

Updated: Jul 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Progress on reasech of drug-coated stent].

Lianpeng Zhang1, Jingxiao Liu

  • 1Department of Material Science and Engineering, Dalian Institute of Light Industry, Dalian 116034, China.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi
|March 6, 2007
PubMed
Summary

Drug-coated stents are key innovations in angioplasty to reduce restenosis. This review covers stent implantation, drug release, and polymer-coated designs for drug-eluting stents.

More Related Videos

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Related Experiment Videos

Last Updated: Jul 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

Area of Science:

  • Cardiovascular medicine
  • Biomaterials science
  • Interventional cardiology

Context:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Restenosis, the re-narrowing of arteries after angioplasty, remains a significant clinical challenge.
  • Drug-coated stents represent a technological advancement to mitigate this complication.

Purpose:

  • To review the mechanisms and processes involved in endovascular stent implantation.
  • To elucidate the principles governing drug release from drug-coated stents.
  • To discuss polymer coating designs and the evolution of drug-eluting stents.

Summary:

  • This paper reviews drug-coated stent technology for percutaneous transluminal coronary angioplasty (PTCA).
  • It details endovascular stent implantation processes and the drug release mechanisms of coated stents.
  • Focus is placed on polymer-coated designs and advancements in drug-eluting stents.

Impact:

  • Drug-coated stents significantly reduce restenosis rates following PTCA.
  • Understanding drug release principles optimizes stent design and therapeutic efficacy.
  • This review provides insights into the development and application of advanced stent technologies.